The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...

Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study ...

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...

Increased postoperative opioid consumption was associated with higher probability of new persistent opioid use in opioid-naive patients.

Findings independent of age, pregnancy, and menopausal status. (HealthDay News) — Women have a higher risk for developing long COVID than men, according to a study published online in JAMA ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

No significant associations seen for SLE or AS with prostate cancer or in reverse MR analyses. (HealthDay News) — Genetically predicted rheumatoid arthritis (RA) is causally associated with ...

(HealthDay News) — Heart disease continues to be a leading cause of death, according to a report from the American Heart Association published online in Circulation.